• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自海七鳃鳗的能够结合脑细胞外基质的可变淋巴细胞受体的高分辨率结构

The High-Resolution Structure of a Variable Lymphocyte Receptor From Petromyzon marinus Capable of Binding to the Brain Extracellular Matrix.

作者信息

Appelt Elizabeth A, Thoden James B, Gehrke Seth A, Bachmeier Hannah D, Rayment Ivan, Shusta Eric V, Holden Hazel M

机构信息

Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.

出版信息

Proteins. 2025 Apr;93(4):801-811. doi: 10.1002/prot.26768. Epub 2024 Nov 27.

DOI:10.1002/prot.26768
PMID:39601379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11878203/
Abstract

Variable lymphocyte receptors (VLRs) are antigen receptors derived from the adaptive immune system of jawless vertebrates such as lamprey ( Petromyzon marinus ). First discovered in 2004, VLRs have been the subject of numerous biochemical and structural investigations. Due to their unique antigen binding properties, VLRs have been leveraged as possible drug delivery agents. One such VLR, previously identified and referred to as P1C10, was shown to bind to the brain extracellular matrix. Here, we present the high-resolution X-ray crystal structure of this VLR determined to 1.3 Å resolution. The fold is dominated by a six-stranded mixed β-sheet which provides a concave surface for possible antigen binding. Electron density corresponding to a 4-(2-hydroxyethyl)piperazine-1-propanesulfonic acid buffer molecule (HEPPS) was found in this region. By comparing the P1C10 molecular architecture and its buffer binding residues with those of other VLRs previously reported, it was possible to illustrate how this unique class of proteins can accommodate diverse binding partners. Additionally, we provide an analysis of the experimentally determined structure compared to the models generated by the commonly used AlphaFold and iTASSER structure prediction software packages.

摘要

可变淋巴细胞受体(VLRs)是源自七鳃鳗(如海七鳃鳗)等无颌脊椎动物适应性免疫系统的抗原受体。VLRs于2004年首次被发现,此后一直是众多生物化学和结构研究的对象。由于其独特的抗原结合特性,VLRs已被用作可能的药物递送剂。一种先前已鉴定并称为P1C10的VLR,被证明可与脑细胞外基质结合。在此,我们展示了该VLR的高分辨率X射线晶体结构,其分辨率达到1.3 Å。该结构的折叠主要由一个六链混合β-折叠片层主导,为可能的抗原结合提供了一个凹面。在该区域发现了对应于4-(2-羟乙基)哌嗪-1-丙磺酸缓冲分子(HEPPS)的电子密度。通过将P1C10的分子结构及其缓冲结合残基与先前报道的其他VLRs进行比较,能够说明这类独特的蛋白质如何容纳不同的结合伙伴。此外,我们还提供了与常用的AlphaFold和iTASSER结构预测软件包生成的模型相比,对实验确定的结构的分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/c412bf437465/PROT-93-801-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/088ae7a632f6/PROT-93-801-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/9de54f6d9699/PROT-93-801-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/74f5623f878e/PROT-93-801-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/673283048abc/PROT-93-801-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/832c265ab4ce/PROT-93-801-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/c412bf437465/PROT-93-801-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/088ae7a632f6/PROT-93-801-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/9de54f6d9699/PROT-93-801-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/74f5623f878e/PROT-93-801-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/673283048abc/PROT-93-801-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/832c265ab4ce/PROT-93-801-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11878203/c412bf437465/PROT-93-801-g003.jpg

相似文献

1
The High-Resolution Structure of a Variable Lymphocyte Receptor From Petromyzon marinus Capable of Binding to the Brain Extracellular Matrix.来自海七鳃鳗的能够结合脑细胞外基质的可变淋巴细胞受体的高分辨率结构
Proteins. 2025 Apr;93(4):801-811. doi: 10.1002/prot.26768. Epub 2024 Nov 27.
2
Structural diversity of the hagfish variable lymphocyte receptors.盲鳗可变淋巴细胞受体的结构多样性。
J Biol Chem. 2007 Mar 2;282(9):6726-32. doi: 10.1074/jbc.M608471200. Epub 2006 Dec 27.
3
VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies.VLR 识别 TLR5 扩展了非 Ig 类抗体的蛋白质抗原结合的分子特征分析。
J Mol Biol. 2018 Apr 27;430(9):1350-1367. doi: 10.1016/j.jmb.2018.03.016. Epub 2018 Mar 26.
4
Alternative adaptive immunity in jawless vertebrates.无颌脊椎动物的替代性适应性免疫。
J Immunol. 2010 Aug 1;185(3):1367-74. doi: 10.4049/jimmunol.0903128.
5
Crystal structure of the lamprey variable lymphocyte receptor C reveals an unusual feature in its N-terminal capping module.七鳃鳗可变淋巴细胞受体C的晶体结构揭示了其N端封端模块的一个不寻常特征。
PLoS One. 2014 Jan 23;9(1):e85875. doi: 10.1371/journal.pone.0085875. eCollection 2014.
6
Crystal structure of an anti-idiotype variable lymphocyte receptor.抗独特型可变淋巴细胞受体的晶体结构
Acta Crystallogr F Struct Biol Commun. 2017 Dec 1;73(Pt 12):682-687. doi: 10.1107/S2053230X1701620X. Epub 2017 Nov 14.
7
Antigen recognition by variable lymphocyte receptors.可变淋巴细胞受体的抗原识别
Science. 2008 Sep 26;321(5897):1834-7. doi: 10.1126/science.1162484.
8
Organization of lamprey variable lymphocyte receptor C locus and repertoire development.七鳃鳗可变淋巴细胞受体 C 基因座的组织和库的发育。
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6043-8. doi: 10.1073/pnas.1302500110. Epub 2013 Mar 4.
9
Identification of Glycan-Specific Variable Lymphocyte Receptors Using Yeast Surface Display and Glycan Microarrays.利用酵母表面展示和糖基化微阵列鉴定糖基特异性可变淋巴细胞受体。
Methods Mol Biol. 2022;2421:73-89. doi: 10.1007/978-1-0716-1944-5_5.
10
Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey.盲鳗海七鳃鳗可变淋巴细胞受体的体细胞多样化
Nature. 2004 Jul 8;430(6996):174-80. doi: 10.1038/nature02740.

引用本文的文献

1
A method for facile production of variable lymphocyte receptors using SHuffle Escherichia coli.一种使用SHuffle大肠杆菌轻松生产可变淋巴细胞受体的方法。
Biotechnol Prog. 2025 May-Jun;41(3):e3530. doi: 10.1002/btpr.3530. Epub 2025 Jan 23.

本文引用的文献

1
Evolution of two distinct variable lymphocyte receptors in lampreys: VLRD and VLRE.在七鳃鳗中进化出两种不同的可变淋巴细胞受体:VLRD 和 VLRE。
Cell Rep. 2023 Aug 29;42(8):112933. doi: 10.1016/j.celrep.2023.112933. Epub 2023 Aug 4.
2
I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction.I-TASSER-MTD:一个基于深度学习的多领域蛋白质结构和功能预测平台。
Nat Protoc. 2022 Oct;17(10):2326-2353. doi: 10.1038/s41596-022-00728-0. Epub 2022 Aug 5.
3
Dali server: structural unification of protein families.
达尔服务器:蛋白质家族的结构统一。
Nucleic Acids Res. 2022 Jul 5;50(W1):W210-W215. doi: 10.1093/nar/gkac387.
4
Identification of lamprey variable lymphocyte receptors that target the brain vasculature.鉴定针对脑血管的七鳃鳗可变淋巴细胞受体。
Sci Rep. 2022 Apr 11;12(1):6044. doi: 10.1038/s41598-022-09962-8.
5
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
6
Identification of variable lymphocyte receptors that can target therapeutics to pathologically exposed brain extracellular matrix.鉴定可将治疗药物靶向递送至病理性暴露的脑细胞外基质的可变淋巴细胞受体。
Sci Adv. 2019 May 15;5(5):eaau4245. doi: 10.1126/sciadv.aau4245. eCollection 2019 May.
7
The variable lymphocyte receptor as an antibody alternative.可变淋巴细胞受体作为抗体的替代品。
Curr Opin Biotechnol. 2018 Aug;52:74-79. doi: 10.1016/j.copbio.2018.02.016. Epub 2018 Mar 26.
8
VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies.VLR 识别 TLR5 扩展了非 Ig 类抗体的蛋白质抗原结合的分子特征分析。
J Mol Biol. 2018 Apr 27;430(9):1350-1367. doi: 10.1016/j.jmb.2018.03.016. Epub 2018 Mar 26.
9
Structural Insights into VLR Fine Specificity for Blood Group Carbohydrates.结构洞察 VLR 对血型碳水化合物的精细特异性。
Structure. 2017 Nov 7;25(11):1667-1678.e4. doi: 10.1016/j.str.2017.09.003. Epub 2017 Oct 5.
10
Genetic engineering of chimeric antigen receptors using lamprey derived variable lymphocyte receptors.利用七鳃鳗来源的可变淋巴细胞受体进行嵌合抗原受体的基因工程。
Mol Ther Oncolytics. 2016 Dec 7;3:16026. doi: 10.1038/mto.2016.26. eCollection 2016.